First Time Loading...

Inventiva SA
NASDAQ:IVA

Watchlist Manager
Inventiva SA Logo
Inventiva SA
NASDAQ:IVA
Watchlist
Price: 3.16 USD -2.47% Market Closed
Updated: Apr 26, 2024

Intrinsic Value

IVA's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Inventiva SA engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases. [ Read More ]

The intrinsic value of one IVA stock under the Base Case scenario is 2.58 USD. Compared to the current market price of 3.16 USD, Inventiva SA is Overvalued by 18%.

Key Points:
IVA Intrinsic Value
Base Case
2.58 USD
Overvaluation 18%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Inventiva SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling IVA stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Inventiva SA

Provide an overview of the primary business activities
of Inventiva SA.

What unique competitive advantages
does Inventiva SA hold over its rivals?

What risks and challenges
does Inventiva SA face in the near future?

Summarize the latest earnings call
of Inventiva SA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Inventiva SA.

Provide P/S
for Inventiva SA.

Provide P/E
for Inventiva SA.

Provide P/OCF
for Inventiva SA.

Provide P/FCFE
for Inventiva SA.

Provide P/B
for Inventiva SA.

Provide EV/S
for Inventiva SA.

Provide EV/GP
for Inventiva SA.

Provide EV/EBITDA
for Inventiva SA.

Provide EV/EBIT
for Inventiva SA.

Provide EV/OCF
for Inventiva SA.

Provide EV/FCFF
for Inventiva SA.

Provide EV/IC
for Inventiva SA.

Show me price targets
for Inventiva SA made by professional analysts.

What are the Revenue projections
for Inventiva SA?

How accurate were the past Revenue estimates
for Inventiva SA?

What are the Net Income projections
for Inventiva SA?

How accurate were the past Net Income estimates
for Inventiva SA?

What are the EPS projections
for Inventiva SA?

How accurate were the past EPS estimates
for Inventiva SA?

What are the EBIT projections
for Inventiva SA?

How accurate were the past EBIT estimates
for Inventiva SA?

Compare the revenue forecasts
for Inventiva SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Inventiva SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Inventiva SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Inventiva SA compared to its peers.

Compare the P/E ratios
of Inventiva SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Inventiva SA with its peers.

Analyze the financial leverage
of Inventiva SA compared to its main competitors.

Show all profitability ratios
for Inventiva SA.

Provide ROE
for Inventiva SA.

Provide ROA
for Inventiva SA.

Provide ROIC
for Inventiva SA.

Provide ROCE
for Inventiva SA.

Provide Gross Margin
for Inventiva SA.

Provide Operating Margin
for Inventiva SA.

Provide Net Margin
for Inventiva SA.

Provide FCF Margin
for Inventiva SA.

Show all solvency ratios
for Inventiva SA.

Provide D/E Ratio
for Inventiva SA.

Provide D/A Ratio
for Inventiva SA.

Provide Interest Coverage Ratio
for Inventiva SA.

Provide Altman Z-Score Ratio
for Inventiva SA.

Provide Quick Ratio
for Inventiva SA.

Provide Current Ratio
for Inventiva SA.

Provide Cash Ratio
for Inventiva SA.

What is the historical Revenue growth
over the last 5 years for Inventiva SA?

What is the historical Net Income growth
over the last 5 years for Inventiva SA?

What is the current Free Cash Flow
of Inventiva SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Inventiva SA.

Financials

Balance Sheet Decomposition
Inventiva SA

Current Assets 48.2m
Cash & Short-Term Investments 26.9m
Receivables 16.2m
Other Current Assets 5.1m
Non-Current Assets 21.4m
PP&E 9.1m
Intangibles 541k
Other Non-Current Assets 11.7m
Current Liabilities 50.2m
Accounts Payable 37.7m
Accrued Liabilities 3.6m
Other Current Liabilities 8.9m
Non-Current Liabilities 51.4m
Long-Term Debt 32.2m
Other Non-Current Liabilities 19.3m
Efficiency

Earnings Waterfall
Inventiva SA

Revenue
17.5m EUR
Operating Expenses
-120.1m EUR
Operating Income
-102.7m EUR
Other Expenses
-7.8m EUR
Net Income
-110.4m EUR

Free Cash Flow Analysis
Inventiva SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

IVA Profitability Score
Profitability Due Diligence

Inventiva SA's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional 1-Year Revenue Growth
Negative Revenue Growth Forecast
Declining ROE
20/100
Profitability
Score

Inventiva SA's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

IVA Solvency Score
Solvency Due Diligence

Inventiva SA's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Low D/E
Positive Net Debt
Short-Term Solvency
Long-Term Solvency
45/100
Solvency
Score

Inventiva SA's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IVA Price Targets Summary
Inventiva SA

Wall Street analysts forecast IVA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IVA is 12.22 USD with a low forecast of 6.61 USD and a high forecast of 16.72 USD.

Lowest
Price Target
6.61 USD
109% Upside
Average
Price Target
12.22 USD
287% Upside
Highest
Price Target
16.72 USD
429% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

IVA Price
Inventiva SA

1M 1M
-14%
6M 6M
-12%
1Y 1Y
+46%
3Y 3Y
-73%
5Y 5Y
+17%
10Y 10Y
-65%
Annual Price Range
3.04
52w Low
2.08
52w High
4.3
Price Metrics
Average Annual Return 48.63%
Standard Deviation of Annual Returns 111.5%
Max Drawdown -87%
Shares Statistics
Market Capitalization 158.4m EUR
Shares Outstanding 52 371 085
Percentage of Shares Shorted
N/A

IVA Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Inventiva SA Logo
Inventiva SA

Country

France

Industry

Biotechnology

Market Cap

158.4m USD

Dividend Yield

0%

Description

Inventiva SA engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases. The company is headquartered in Daix, Occitanie and currently employs 100 full-time employees. The company went IPO on 2017-02-15. The firm focuses on the development of therapies in the area of oncology, fibrosis and rare diseases. The Company’s pipeline comprises a number of development programs, such as Clinical Pipeline, Preclinical Pipeline, AbbVie Collaboration and Boehringer-Ingelheim collaboration. Its drug candidates target at the treatment of non-alcoholic steatohepatitis (NASH), systemic sclerosis (SSc), various types of mucopolysaccharidosis (MPS), multiple myeloma, auto-immune disorders, as well as lung cancer, among others. In addition, the Company offers drug discovery services, ranging from target identification to preclinical nomination, in numerous areas, such as silico modelling, biology, screening, absorption, distribution, metabolism and excretion (ADME), pharmacology and histology.

Contact

OCCITANIE
Daix
50 rue de Dijon, Daix
+33380447500.0
http://inventivapharma.com/

IPO

2017-02-15

Employees

100

Officers

Co-Founder, CEO & Chairman
Mr. Frederic Cren
Co-Founder, Chief Scientific Officer, Deputy CEO & Director
Dr. Pierre Broqua Ph.D.
Chief Financial Officer
Mr. Jean Volatier
Chief Operating Officer
Alice Roudot-Ketelers Pharm.D.
General Counsel
Mr. Eric Duranson L.L.M.
Head of Human Resources
Ms. Nathalie Harroy
Show More
Chief Medical Officer
Dr. Michael Cooreman
Executive VP of Strategy & Corporate Affairs
Pascaline Clerc Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one IVA stock?

The intrinsic value of one IVA stock under the Base Case scenario is 2.58 USD.

Is IVA stock undervalued or overvalued?

Compared to the current market price of 3.16 USD, Inventiva SA is Overvalued by 18%.